Work

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases

Year: 2016

Type: article

Study design: Observational Study

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.10.015

Authors: Hironori Uruga, Emine Bozkurtlar, Tiffany G. Huynh, Alona Muzikansky, Yasushi Goto, Maria Gomez-Caraballo, Aaron N. Hata, Justin F. Gainor, Eugene J. Mark, Jeffrey A. Engelman, Michael D. Lanuti, Mari Mino-Kenudson

Institutions: Massachusetts General Hospital, National Cancer Center Hospital, Harvard University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2546935275

FWCI: 8.653

Cites: 42

Cited by: 128

Related to: 10